The global coffee market is entering a bearish phase due to improving supply expectations, especially from Brazil's 2026/27 crop, which is projected to yield 71-76 million bags. This outlook is driving arabica and robusta prices down despite ongoing logistical issues and low certified stock levels. While physical market signals show near-term tightness in arabica and increased robusta exports from Vietnam, the market is primarily focused on the anticipated Brazilian abundance.

Cetera Financial Group and Raymond James & Associates have both announced additions to their advisor ranks, collectively adding teams that oversee more than $550 million in client assets. Cetera welcomed MTI Financial Advisors, a Minnesota-based fiduciary practice managing $350 million, from Osaic. Meanwhile, Raymond James added The Arney Group, comprising advisors C. Drew Arney and Grant Watson III, who previously managed over $200 million at Truist Investment Services in Roanoke, Virginia.

Broadridge Financial Solutions, Inc. has announced its participation in Anthropic's Project Glasswing, an initiative focused on leveraging frontier AI models to secure critical software and enhance cyber defense within the financial services industry. Through this collaboration, Broadridge will apply these advanced AI models to its own systems to proactively address emerging threats and bolster the overall security of the financial ecosystem. The project aims to strengthen defensive security efforts across foundational systems shared by critical infrastructure.

Broadridge (NYSE:BR) has joined Anthropic's Project Glasswing, an industry initiative aimed at securing critical software and strengthening cyber defense using frontier AI models. This partnership will involve applying Anthropic's unreleased Claude Mythos Preview model to Broadridge's systems, specifically targeting financial services infrastructure. The collaboration underscores Broadridge's ongoing commitment to leveraging advanced AI for enhanced cybersecurity and operational resilience.

Paramount Gold Nevada Corp. has announced positive results from an Initial Assessment for its Sleeper Gold Project, outlining a potential 17-year restart. The study reveals a base case after-tax NPV of $402 million and an IRR of 45% at $3,600/oz gold, with an upside case raising NPV to $867 million at $4,700/oz gold. The project, which involves processing existing waste rock dumps and mining oxide and mixed mineral resources, anticipates producing 1.1 million ounces of payable gold and 3.38 million ounces of silver over its mine life.

This article covers several key developments in the biopharma industry, including Moderna's alignment with the FDA for its mRNA flu vaccine ahead of an advisory committee meeting. It also highlights a surge in biotech IPOs, with Kailera Therapeutics and Parabilis Medicines setting new records, alongside ongoing biopharma layoffs primarily from Takeda and BioNTech. Additionally, the piece touches on Eli Lilly's dealmaking and positive clinical results, and concerns surrounding the FDA’s National Priority Voucher program.

Paramount Gold Nevada Corp. announced strong initial assessment results for its Sleeper Gold Project, projecting an after-tax NPV of $402 million and an IRR of 45% based on current gold prices, with potential for $867 million NPV and 66% IRR in an upside scenario. The project, which utilizes existing waste rock and infrastructure, boasts a short payback period of 1.4 years and a 17-year mine life, emphasizing the significant economic potential and future growth opportunities from additional resource conversion and exploration. The study reinforces Sleeper's position as a promising redevelopment asset for Paramount.

BofA Securities increased its price target for CSX Corp. to $53 from $51, maintaining a Buy rating due to stronger-than-expected carload performance in Q2 2026. The firm noted significant year-over-year increases in intermodal and coal volumes, revising its carload growth estimate for CSX upwards. Despite the positive outlook, InvestingPro analysis suggests CSX is currently overvalued relative to its Fair Value estimate.

Heard Capital LLC significantly increased its stake in Transdigm Group (TDG) by 8.9% in the fourth quarter, now holding 170,629 shares valued at $226.9 million, making it their second-largest holding. Institutional interest in TDG remains high, with several major firms also increasing their positions, bringing total institutional ownership to 95.78%. Conversely, company insiders have been engaged in significant selling activity, offloading 28,064 shares worth approximately $34.3 million in the last three months.

Mar Vista Investment Partners LLC reduced its stake in Transdigm Group (NYSE:TDG) by 5.4% during the fourth quarter, selling 2,258 shares but still holding 39,791 shares valued at $52.9 million, making TDG its 6th largest holding. Despite this, analyst sentiment remains largely positive with a "Moderate Buy" consensus and a $1,525.06 price target, although some firms have recently lowered targets. The article also highlights significant insider selling, with 28,064 shares worth $34.3 million sold by corporate insiders in the last 90 days.